RecruitingNot ApplicableNCT07094100

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects

Clinical Study of Cartilage Constructed by Autologous Bone Marrow Mesenchymal Stem Cells in Repairing Articular Cartilage Defects

Sponsor

The First Affiliated Hospital of Xinxiang Medical College

Enrollment

30 participants

Start Date

Apr 20, 2026

Study Type

INTERVENTIONAL

Conditions

Cartilage Injury OA Knee

Summary

The joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Tissue engineered cartilage for people with cartilage injury and oa knee. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.